Clinical Trials Directory

Trials / Conditions / Stage IA Pancreatic Cancer

Stage IA Pancreatic Cancer

13 registered clinical trials studyying Stage IA Pancreatic Cancer.

StatusTrialSponsorPhase
CompletedVX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer
NCT03373188
Emory UniversityPhase 1
TerminatedPreoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study
NCT02345460
Case Comprehensive Cancer CenterPhase 2
CompletedElectronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in P
NCT02511821
City of Hope Medical CenterN/A
CompletedNeoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Canc
NCT02349867
Virginia Commonwealth UniversityPhase 1
CompletedNeoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer
NCT01918644
University of Wisconsin, MadisonPhase 1
WithdrawnMetformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery
NCT01954732
Case Comprehensive Cancer CenterPhase 1
WithdrawnPatient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancr
NCT02414100
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University—
CompletedChemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer
NCT01959672
University of NebraskaPhase 2
CompletedDasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreati
NCT01234935
Translational Oncology Research InternationalPhase 2
TerminatedRO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
NCT01192763
National Cancer Institute (NCI)Phase 1
CompletedPerioperative Therapy for Resectable Pancreatic Cancer
NCT00609336
University of WashingtonPhase 2
TerminatedErlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
NCT00482625
National Cancer Institute (NCI)Phase 2
CompletedBevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patien
NCT00305877
National Cancer Institute (NCI)Phase 2